Zhi Tong Cai Jing·2025-07-02 04:10Market Overview - The Hang Seng Index rose by 0.62%, gaining 148 points to close at 24,220 points, while the Hang Seng Tech Index fell by 0.27%. The early trading volume in Hong Kong was HKD 135.2 billion [1]. Copper Industry - Recent strong performance in copper prices has led institutions to believe that prices are likely to rise further. Copper mining stocks generally increased, with China Nonferrous Mining (01258) up by 2%, Zijin Mining (601899) (02899) up by 2.99%, and Jiangxi Copper (600362) (00358) up by 2.36% [1]. Cobalt Market - Luoyang Molybdenum (603993) (03993) saw a 4.14% increase, reaching a new high, as Bank of America noted that soaring cobalt prices offset the impact of extended cobalt export bans [2]. Gold Sector - Most gold stocks rose, with Shandong Gold (600547) (01787) increasing by 6.24% to reach a new peak, and Zijin Mining (02899) rising over 2.99% [3]. Banking Sector - Chinese banks' stocks experienced broad gains in early trading, with institutions indicating that H-shares are more attractive compared to A-shares. Notable increases included Minsheng Bank (600016) (01988) up by 4.72%, CITIC Bank (601998) (00998) up by 2.54%, and China Construction Bank (601939) (00939) up by 3.16% [3]. Photovoltaic Industry - The news of production cuts in photovoltaic glass has been confirmed, leading to expectations of accelerated elimination of outdated capacity in the industry. Stocks in this sector rose significantly, with Fuyao Glass (601865) (06865) up by 8.4% and Xinyi Solar (00968) up by 7.63% [3]. Beverage Sector - Nayuki's Tea (02150) surged over 35%, with a continuous two-month double-digit growth in order volume, indicating significant growth potential [4]. Food Industry - Guoquan (02517) rose over 18% after announcing plans to invest HKD 490 million in a food production base in Hainan, with institutions noting a recovery in same-store sales [5]. Jewelry Sector - Luk Fook Holdings (00590) increased by 3.99%, with institutions stating that the operational performance for the second half of the fiscal year 2025 exceeded expectations, and the company plans to resume store expansion [6]. Biotechnology Sector - JACOB-23E73 completed its first patient dosing in the U.S. for Phase I/IIa clinical trials, leading to a rise of over 7% in shares of JACOB (01167) [7]. Automotive Sector - Li Auto-W (02015) fell by 2.4%, with June delivery volumes down 24% year-on-year, following a previous downward revision of second-quarter guidance [8].